| Apr 12 2023 |
What New York Employers Need to Know About Marijuana Two Years After Legalization |
Jackson Lewis P.C. |
| Apr 12 2023 |
Food Chemicals Ban Bill Moves Forward in California Assembly |
Keller and Heckman LLP |
| Apr 12 2023 |
APHIS Seeks Comment on Draft Environmental Documents for Deregulation of Corn Developed Using Genetic Engineering |
Bergeson & Campbell, P.C. |
| Apr 12 2023 |
Preparing for Liquor License Renewal 2023-2024: Requirements, Deadlines and Best Practices |
Varnum LLP |
| Apr 12 2023 |
North Carolina Court Dismisses Employee’s Disability Suit Over Lawful Use of CBD |
Jackson Lewis P.C. |
| Apr 12 2023 |
Pennsylvania Court Holds Employer Must Reimburse Out-of-Pocket Costs for Medical Marijuana |
Jackson Lewis P.C. |
| Apr 11 2023 |
New California Bill Seeks to Eliminate Certain Food Additives |
Sheppard, Mullin, Richter & Hampton LLP |
| Apr 11 2023 |
“Dietary Guidance Statements” in Food Labeling: What You Need to Know About FDA’s Latest Draft Guidance for the Food Industry |
Sheppard, Mullin, Richter & Hampton LLP |
| Apr 11 2023 |
FDA Publishes Proposed Rule Permitting Salt Substitutes in Standardized Foods |
Keller and Heckman LLP |
| Apr 11 2023 |
This Week in 340B: April 4 – 10, 2023 |
McDermott Will & Schulte LLP |
| Apr 11 2023 |
Solicitor General Provides Views of the United States on Section VIII Carve-Outs, Induced Patent Infringement in GSK v. Teva |
Greenberg Traurig, LLP |
| Apr 11 2023 |
Green Marketing Claims to Receive Increased Scrutiny |
Beveridge & Diamond PC |
| Apr 10 2023 |
FDA To Require Demonstration of Cybersecurity Safeguards for Pre-Market Submissions of Certain Medical Devices |
Sheppard, Mullin, Richter & Hampton LLP |
| Apr 10 2023 |
Khan's FTC Reportedly Reviving Price Discrimination Law to Investigate What Big Retailers Pay for Cola |
MoginRubin |
| Apr 10 2023 |
Honey I Shrunk the Whisky? Class Action Alleges Fraud over Mini Bottle Labeling |
ArentFox Schiff LLP |
| Apr 10 2023 |
Plaintiffs Argue There is No Evidence FDA Will Act Soon on “Natural” Definition |
Keller and Heckman LLP |
| Apr 10 2023 |
What FQHCs Need to Know About Telehealth After the PHE |
Foley & Lardner LLP |
| Apr 8 2023 |
Statement from Attorney General Merrick B. Garland |
The U.S. Department of Justice |
| Apr 7 2023 |
Texas Lab Settles Unnecessary Drug Testing Allegations for $6 Million |
ArentFox Schiff LLP |
| Apr 7 2023 |
Potential Nitrosamine Contamination Results in Another Voluntary Pharmaceutical Recall |
Nelson Mullins |
| Apr 7 2023 |
When Keeping Medication Safe May Lead to Increased Liability |
McDermott Will & Schulte LLP |
| Apr 7 2023 |
CMS Issues Medicare Drug Price Negotiation Initial Guidance, First Inflation Rebate List |
McDermott Will & Schulte LLP |
| Apr 7 2023 |
CMS Updates Could Help Employers on Second Round of Drug Cost Reporting |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Apr 6 2023 |
No Smoking Gun Here: Soliciting Input Sufficient to Satisfy Commission’s Statutory Obligation |
McDermott Will & Schulte LLP |
| Apr 6 2023 |
News Alert: Public Consultation on the EU’s Tobacco Products Legislation: Comment Period Open Until May 16, 2023 |
Keller and Heckman LLP |
| Apr 6 2023 |
DOC’s Bureau of Economic Analysis Releases Report on Developing a National Measure of the Economic Contributors of the Bioeconomy |
Bergeson & Campbell, P.C. |
| Apr 6 2023 |
FDA Announces First-Ever AI/ML Medical Device Draft Guidance |
Nelson Mullins |
| Apr 5 2023 |
D’Addario v. Johnson & Johnson – New Jersey Federal Court Addresses Express Pre-Emption In Class III Medical Device Case |
Sills Cummis & Gross P.C. |
| Apr 5 2023 |
“All Fruit” Jelly Label Continues to be Challenged in New York Federal Court |
Keller and Heckman LLP |
| Apr 5 2023 |
DOD Publishes Biomanufacturing Strategy and RFI on Biomanufactured Products and Process Capabilities |
Bergeson & Campbell, P.C. |
| Apr 4 2023 |
Is CMS Ignoring the Realities of Biopharmaceutical Costs? |
Epstein Becker & Green, P.C. |
| Apr 4 2023 |
COVID-19 Related Medical Devices: FDA Finalizes Transition Plan Guidance |
Foley & Lardner LLP |
| Apr 4 2023 |
Unpacking Averages: FDA FOIA Response Times by Topic of Request |
Epstein Becker & Green, P.C. |
| Apr 4 2023 |
Lawsuit Forces Early Release of NTP’s Draft Report on Fluoride, and its Potential Association with Neurodevelopment and Cognition |
ArentFox Schiff LLP |
| Apr 4 2023 |
White House Report Identifies Precision Medicine for Future R & D Investment |
Foley & Lardner LLP |
